NCT01919619
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +24 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,108 public trials
2,040 recruiting studies
Lymphoproliferative Disorders trial results
NCT04436029
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Center for Cancer and Blood Disorders Bethesda, Maryland, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Stephenson Cancer Center Oklahoma University Health Science Centers Oklahoma City, Oklahoma, United States
- Medical College of Wisconsin Madison, Wisconsin, United States
NCT03307746
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- The Christie NHS Foundation Trust Manchester, United Kingdom
- Oxford University Hospitals NHS Foundation Trust Oxford, United Kingdom
- Plymouth Hospitals NHS Trust Plymouth, United Kingdom
- University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom
Completed
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
NCT04233034
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +13 more
- Locations
-
- Stanford University Palo Alto, California, United States
- Barbara Davis Center Aurora, Colorado, United States
- Yale University New Haven, Connecticut, United States
- Indiana University Indianapolis, Indiana, United States
NCT05620420
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +27 more
- Locations
-
- shanghai Jiaotong University School of Medicine, Renji Hospital Shanghai, Shanghai Municipality, China
NCT02549833
- Conditions
- Astrocytoma, Astrocytoma, Grade II, Glioma, +19 more
- Locations
-
- University of California San Francisco, California, United States
NCT04930536
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma, Disease Attributes, +18 more
- Locations
-
- Research Site Ahmedabad, India
- Research Site Bangalore, India
- Research Site Bangalore, India
- Research Site Bengaluru, India
Completed
MB-CART20.1 Lymphoma
NCT03664635
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Disease Attributes, +15 more
- Locations
-
- University Hospital of Cologne - Clinic for Internal Medicine I Cologne, Germany
- Universitätsklikum Leipzig, AöR Leipzig, Germany
NCT02406092
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Hôpital Dorban CHU Annaba, Service d'Hématologie Annaba, Algeria
- EHS CAC Hospital FRANTZ FANON ZABANA BLIDA; Hematology ward Blida, Algeria
- EHU Oran, Service d'Hématologie et de Thérapie Cellulaire Oran, Algeria
- Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie Tizi Ouzou, Algeria
NCT05896774
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
- Sir Run Run Shaw Hospital Hangzhou, Zhejiang, China